Wegovy — Class II drug recall D-0393-2025
Ongoing recall by Cardinal Health Inc., reported 2025-05-07, distributed in NC, SC, VA. Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled stor
| Recall number | D-0393-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cardinal Health Inc., Dublin, OH, United States |
| Recall initiated | 2025-04-09 |
| Classified | 2025-04-28 |
| Reported by FDA | 2025-05-07 |
| Distributed | NC, SC, VA |
| Quantity | 48 cartons |
| Reason classes | labeling, temperature control |
| NDC | 00169-4524-14 |
| Lot numbers | PZFDE06 |
| Expiration dates | 2025-08-31 |
Product
Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.
Reason for recall
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0393-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.